DV Medical Supply, Inc.

2000 W 135th Street
Gardena, CA. 90249
US

800-438-2568

Famotidine Injection 10mg/mL 20mL MDV
Famotidine Injection 10mg/mL 20mL MDV

Famotidine Injection 10mg/mL 20mL MDV

In Stock.
Part Number:DVM-100288
  • Order Limit:5
  • Disclaimer:This product requires special handling and is shipped overnight delivery. Customer assumes responsibility if the package is undeliverable for any reason. Address verification and business hours of operation for package receipt is the responsibility of the customer.
MPN:
Manufacturer: Fresenius USA

NDC:

63323-0738-20
You need to have an approved DV Med account to order this product.

Famotidine injection, supplied as a concentrated solution for intravenous injection, is intended for intravenous use only.  Famotidine injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in patients who are unable to take oral medication for the following conditions:
  1. Short term treatment of active duodenal ulcer.  Most adult patients heal within 4 weeks; there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks.  Studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than 8 weeks.
  2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer.  Controlled studies in adults have not extended beyond one year.
  3. Short term treatment of active benign gastric ulcer.  Most adult patients heal within 6 weeks.  Studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks.
  4. Short term treatment of gastroesophageal reflux disease (GERD).  Famotidine is indicated for short term treatment of patients with symptoms of GERD (see  CLINICAL PHARMACOLOGY IN ADULTS ,CLINICAL STUDIES). Famotidine is also indicated for the short term treatment of esophagitis due to GERD including erosive or ulcerative disease diagnosed by endoscopy (see CLINICAL PHARMACOLOGY IN ADULTS ,CLINICAL STUDIES).
  5. Treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine adenomas) (see CLINICAL PHARMACOLOGY IN ADULTS ,CLINICAL STUDIES).

Related Items